291 related articles for article (PubMed ID: 15943163)
1. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge.
Sarkar C; Chand Sharma M; Nayak A; Mercy Ralte A; Gupta V; Singh S; Behari M
Clin Neuropathol; 2005; 24(3):118-25. PubMed ID: 15943163
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy as an early marker of AL amyloidosis.
Duston MA; Skinner M; Anderson J; Cohen AS
Arch Intern Med; 1989 Feb; 149(2):358-60. PubMed ID: 2537065
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
[TBL] [Abstract][Full Text] [Related]
4. Primary systemic amyloidosis presenting with demyelinating features.
Gutierrez A; Turkewitz LJ; Correa H; England JD
Neurol Neurophysiol Neurosci; 2006 Dec; ():6. PubMed ID: 17260083
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
Swan N; Skinner M; O'Hara CJ
Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
[TBL] [Abstract][Full Text] [Related]
6. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow.
Gertz MA; Greipp PR; Kyle RA
J Lab Clin Med; 1991 Jul; 118(1):33-9. PubMed ID: 1906082
[TBL] [Abstract][Full Text] [Related]
7. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.
Li K; Kyle RA; Dyck PJ
Am J Pathol; 1992 Jul; 141(1):217-26. PubMed ID: 1321563
[TBL] [Abstract][Full Text] [Related]
9. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
[TBL] [Abstract][Full Text] [Related]
10. [Primary systemic amyloidosis presenting as polymyalgia rheumatica and giant cell arteritis].
Pantoja Zarza L; Paniagua De La Riva J; Megido Lahera M; Ortiz De Saracho J
An Med Interna; 2001 Apr; 18(4):205-7. PubMed ID: 11496541
[TBL] [Abstract][Full Text] [Related]
11. [A case of kappa L-chain primary nodular lung amyloidosis].
Kosacka M; Wojtala R; Piesiak P; Passowicz-Muszyńska E; Jankowska R
Pol Merkur Lekarski; 2008 Dec; 25(150):516-8. PubMed ID: 19205385
[TBL] [Abstract][Full Text] [Related]
12. AL-amyloidosis is underdiagnosed in renal biopsies.
Novak L; Cook WJ; Herrera GA; Sanders PW
Nephrol Dial Transplant; 2004 Dec; 19(12):3050-3. PubMed ID: 15507480
[TBL] [Abstract][Full Text] [Related]
13. [Myopathy and mixed hyperlipoproteinemia as the first symptom of systemic AL-amyloidosis].
Tosovský M; Soukup T; Bradna P; Maisnar V; Tycová V; Toms J; Prixová M
Vnitr Lek; 2008 Oct; 54(10):1014-9. PubMed ID: 19009771
[TBL] [Abstract][Full Text] [Related]
14. [Amyloid neuropathy associated with a benign monoclonal gammopathy (lambda light chains)].
Graveleau P; Dairou R; Tritschler JC; Hénin D; Masson M; Cambier J
Rev Neurol (Paris); 1978 Dec; 134(12):773-80. PubMed ID: 224439
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
16. IgM demyelinative neuropathy with amyloidosis and biclonal gammopathy.
Julien J; Vital C; Vallat JM; Lagueny A; Ferrer X; Deminiere C; Leboutet MJ; Effroy C
Ann Neurol; 1984 Apr; 15(4):395-9. PubMed ID: 6430211
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO
Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis.
Shimojima Y; Matsuda M; Gono T; Ishii W; Fushimi T; Hoshii Y; Yamada T; Ikeda S
Amyloid; 2005 Mar; 12(1):33-40. PubMed ID: 16076609
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
